WHO ICTRP trial
Reduction of adverse effects by systemic antihistamines in drug therapy with…
NL-OMON37148 · Overview of Medical Research in the Netherlands (NL-OMON) · Recruiting
Key facts
| Trial ID | NL-OMON37148 |
|---|---|
| Public title | Reduction of adverse effects by systemic antihistamines in drug therapy with fumarates in severe chronic plaque psoriasis: a doubleblind, randomized, placebo controlled clinical trial |
| Scientific title | Reduction of adverse effects by systemic antihistamines in drug therapy with fumarates in severe chronic plaque psoriasis: a doubleblind, randomized, placebo controlled clinical trial - Reduction of adverse effects of fumarates with antihistamines. |
| Primary sponsor | Erasmus MC, Universitair Medisch Centrum Rotterdam |
| Registry | Overview of Medical Research in the Netherlands (NL-OMON) |
| Recruitment status | Recruiting |
| Study type | Interventional |
| Countries | Netherlands |
| Conditions | fumarates side-effects;10014982;fumarates;side-effects |
| Interventions | psoriasis vulgaris ;antihistamines;fumarates;side-effects;therapy |
| Registration date | May 12, 2011 |
| Target size | 50 |
| Secondary IDs | ISRCTN12758639;2009-010137-41;NL26484.078.09 |
| Registry page | onderzoekmetmensen.nl |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: